US Patent Issued to Vestlandets Innovasjonsselskap AS on April 14 for "Method for the treatment of chronic fatigue syndrome using an inhibitory or cytotoxic agent against plasma cells" (Norwegian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,620, issued on April 14, was assigned to Vestlandets Innovasjonsselskap AS (Bergen, Norway).

"Method for the treatment of chronic fatigue syndrome using an inhibitory or cytotoxic agent against plasma cells" was invented by Oystein Fluge (Morvik, Norway) and Olav Mella (Olsvik, Norway).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates in a first aspect to a method for the treatment of chronic fatigue syndrome (CFS) comprising administering to a patient in need thereof a therapeutically effective amount of inhibitory or cytotoxic agent against plasma cells. In a further aspect, the present disclosure relates to a combinati...